September 15, 2017 — Philips highlighted its newest solution for nuclear cardiology, CardioMD IV, at the American Society of Nuclear Cardiology’s Annual Scientific Session, Sept. 14-17 in Kansas City, Mo. CardioMD IV leverages single photon emission computed tomography (SPECT) technology, advanced Astonish reconstruction and cardiac quantification software to deliver diagnostic confidence and improved workflow for cardiac imaging.
The system is tailored to address the most pressing challenges in cardiac imaging today. It was designed to fit the clinical and economic needs of healthcare institutions. With a small footprint, CardioMD IV will fit in virtually any existing camera room without requiring costly renovations. Its patient-friendly design allows for greater positioning flexibility, and half-time cardiac imaging with Astonish reconstruction improves workflow efficiency without sacrificing image quality. Philips’ advanced visualization and analysis platform, IntelliSpace Portal, provides enterprise-wide access to the latest cardiac SPECT quantification, review and reporting applications while enabling effective collaboration among cardiologists and referring physicians.
For more information: www.usa.philips.com/healthcare
Watch the VIDEO "PET vs. SPECT in Nuclear Cardiology and Recent Advances in Technology." An interview with Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and president-elect of the American Society of Nuclear Cardiology (ASNC), explained advances in PET and SPECT imaging.
Watch the VIDEO "Trends in Nuclear Cardiology Imaging." A discussion with David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty.
June 09, 2023 
